Amalio Telenti

53.8k total citations · 14 hit papers
355 papers, 27.0k citations indexed

About

Amalio Telenti is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Amalio Telenti has authored 355 papers receiving a total of 27.0k indexed citations (citations by other indexed papers that have themselves been cited), including 192 papers in Infectious Diseases, 162 papers in Virology and 92 papers in Epidemiology. Recurrent topics in Amalio Telenti's work include HIV Research and Treatment (161 papers), HIV/AIDS drug development and treatment (133 papers) and HIV/AIDS Research and Interventions (66 papers). Amalio Telenti is often cited by papers focused on HIV Research and Treatment (161 papers), HIV/AIDS drug development and treatment (133 papers) and HIV/AIDS Research and Interventions (66 papers). Amalio Telenti collaborates with scholars based in Switzerland, United States and United Kingdom. Amalio Telenti's co-authors include Thomas Bodmer, Hansjakob Furrer, Laurent A. Décosterd, Thierry Buclin, Federica Marchesi, Jérôme Biollaz, Pietro Vernazza, Catia Marzolini, P Francioli and Bernard Hirschel and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Amalio Telenti

352 papers receiving 26.2k citations

Hit Papers

Rapid identification of m... 1993 2026 2004 2015 1993 1993 1999 2000 2001 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis
    1993 1.2k citations Amalio Telenti, Frank Bally et al. profile →
  2. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis
    1993 1.0k citations Amalio Telenti et al. profile →
  3. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study
    1999 772 citations Bruno Ledergerber, Matthias Egger et al. profile →
  4. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study
    2000 692 citations Gilbert Greub, Hansjakob Furrer et al. profile →
  5. Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients
    2001 687 citations Catia Marzolini, Amalio Telenti et al. AIDS profile →
  6. Antiretroviral Treatment of Adult HIV Infection
    2010 595 citations Amalio Telenti, Huldrych F. Günthard et al. profile →
  7. Critical role for the chemokine receptor CXCR6 in NK cell–mediated antigen-specific memory of haptens and viruses
    2010 535 citations Amalio Telenti et al. profile →
  8. Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study
    2002 535 citations Jacques Fellay, Catia Marzolini et al. profile →
  9. A primer on deep learning in genomics
    2018 525 citations Amalio Telenti et al. profile →
  10. Atherogenic Dyslipidemia in HIV-Infected Individuals Treated With Protease Inhibitors
    1999 498 citations Amalio Telenti, Philippe Sudre et al. profile →
  11. The fecal metabolome as a functional readout of the gut microbiome
    2018 481 citations Amalio Telenti et al. profile →
  12. Antiretroviral Treatment of Adult HIV Infection
    2014 352 citations Huldrych F. Günthard, Amalio Telenti et al. profile →
  13. After the pandemic: perspectives on the future trajectory of COVID-19
    2021 255 citations Amalio Telenti, Davide Corti et al. profile →
  14. The Evolution and Biology of SARS-CoV-2 Variants
    2022 110 citations Amalio Telenti, David L. Robertson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amalio Telenti Switzerland 86 15.3k 9.3k 8.7k 5.8k 3.0k 355 27.0k
Bonaventura Clotet Spain 76 16.4k 1.1× 5.1k 0.5× 15.3k 1.8× 3.0k 0.5× 3.4k 1.1× 716 24.8k
Michael M. Lederman United States 78 9.8k 0.6× 6.4k 0.7× 13.1k 1.5× 3.2k 0.6× 8.4k 2.8× 381 24.7k
H. Clifford Lane United States 77 10.0k 0.7× 7.1k 0.8× 12.1k 1.4× 14.5k 2.5× 10.5k 3.5× 309 42.5k
Michael S. Saag United States 84 19.4k 1.3× 9.5k 1.0× 15.5k 1.8× 2.3k 0.4× 3.7k 1.2× 328 28.8k
Michael P. Busch United States 80 10.2k 0.7× 11.2k 1.2× 6.7k 0.8× 2.2k 0.4× 3.6k 1.2× 647 29.2k
Martin Hirsch United States 72 13.6k 0.9× 7.2k 0.8× 13.0k 1.5× 1.9k 0.3× 3.8k 1.3× 274 24.1k
Jeffrey N. Martin United States 79 11.7k 0.8× 6.7k 0.7× 11.6k 1.3× 2.2k 0.4× 5.7k 1.9× 340 23.5k
John Phair United States 69 11.0k 0.7× 7.6k 0.8× 9.5k 1.1× 1.3k 0.2× 4.0k 1.3× 353 22.0k
Brian Gazzard United Kingdom 77 12.2k 0.8× 7.0k 0.8× 8.9k 1.0× 1.0k 0.2× 2.4k 0.8× 494 21.8k
Margaret A. Fischl United States 62 16.5k 1.1× 6.8k 0.7× 12.5k 1.4× 1.4k 0.2× 2.0k 0.7× 268 23.5k

Countries citing papers authored by Amalio Telenti

Since Specialization
Citations

This map shows the geographic impact of Amalio Telenti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amalio Telenti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amalio Telenti more than expected).

Fields of papers citing papers by Amalio Telenti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amalio Telenti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amalio Telenti. The network helps show where Amalio Telenti may publish in the future.

Co-authorship network of co-authors of Amalio Telenti

This figure shows the co-authorship network connecting the top 25 collaborators of Amalio Telenti. A scholar is included among the top collaborators of Amalio Telenti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amalio Telenti. Amalio Telenti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maher, M. Cyrus, István Bartha, Steven Weaver, et al.. (2022). Predicting the mutational drivers of future SARS-CoV-2 variants of concern. Science Translational Medicine. 14(633). eabk3445–eabk3445. 99 indexed citations
2.
Iranmehr, Arya, Tsering Stobdan, Dan Zhou, et al.. (2018). Novel insight into the genetic basis of high-altitude pulmonary hypertension in Kyrgyz highlanders. European Journal of Human Genetics. 27(1). 150–159. 14 indexed citations
3.
Rato, Sylvie, Antonio Rausell, Miguel Muñoz, Amalio Telenti, & Angela Ciuffi. (2017). Single-cell analysis identifies cellular markers of the HIV permissive cell. PLoS Pathogens. 13(10). e1006678–e1006678. 44 indexed citations
4.
Telenti, Amalio, Levi Pierce, William Biggs, et al.. (2016). Deep sequencing of 10,000 human genomes. Proceedings of the National Academy of Sciences. 113(42). 11901–11906. 195 indexed citations
5.
Ciuffi, Angela, Sylvie Rato, & Amalio Telenti. (2016). Single-Cell Genomics for Virology. Viruses. 8(5). 123–123. 32 indexed citations
6.
Telenti, Amalio, et al.. (2015). Sincell : an R/Bioconductor package for statistical assessment of cell-state hierarchies from single-cell RNA-seq. Bioinformatics. 31(20). 3380–3382. 41 indexed citations
7.
Rausell, Antonio, Paul J. McLaren, & Amalio Telenti. (2013). HIV and innate immunity – a genomics perspective. F1000Prime Reports. 5. 29–29. 7 indexed citations
8.
McLaren, Paul J., Jacques Fellay, & Amalio Telenti. (2013). European Genetic Diversity and Susceptibility to Pathogens. Human Heredity. 76(3-4). 187–193. 2 indexed citations
9.
Lubomirov, Rubin, Julia di Iulio, Aurélie Fayet, et al.. (2010). ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir. Pharmacogenetics and Genomics. 20(4). 217–230. 86 indexed citations
10.
Ortiz, M., Nicolas Guex, Étienne Patin, et al.. (2009). Evolutionary Trajectories of Primate Genes Involved in HIV Pathogenesis. Molecular Biology and Evolution. 26(12). 2865–2875. 43 indexed citations
11.
Colombo, Sara, Amalio Telenti, Thierry Buclin, et al.. (2006). Are Plasma Levels Valid Surrogates for Cellular Concentrations of Antiretroviral Drugs in HIV-infected Patients?. Therapeutic Drug Monitoring. 28(3). 332–338. 17 indexed citations
12.
Ortiz, Millán, Gabriela Bleiber, Raquel Martínez, Henrik Kaessmann, & Amalio Telenti. (2006). Patterns of evolution of host proteins involved in retroviral pathogenesis. Retrovirology. 3(1). 11–11. 40 indexed citations
13.
Colombo, Sara, Nicole Soranzo, Margalida Rotger, et al.. (2005). Influence of ABCB1, ABCC1, ABCC2, and ABCG2 haplotypes on the cellular exposure of nelfinavir in vivo. Pharmacogenetics and Genomics. 15(9). 599–608. 63 indexed citations
14.
Ciuffi, Angela, Miguel Muñoz, Gabriela Bleiber, et al.. (2004). Interactions of Processed Nef (58-206) with Virion Proteins of HIV Type 1. AIDS Research and Human Retroviruses. 20(4). 399–407. 6 indexed citations
15.
Fagard, Catherine, Huldrych F. Günthard, Hans H. Hirsch, et al.. (2003). A controlled trial of granulocyte macrophage-colony stimulating factor during interruption of HAART. AIDS. 17(10). 1487–1492. 20 indexed citations
16.
Hirschel, Bernard, Markus Flepp, Heiner C. Bucher, et al.. (2002). Switching from protease inhibitors to efavirenz: differences in efficacy and tolerance among risk groups: a case–control study from the Swiss HIV Cohort. AIDS. 16(3). 381–385. 21 indexed citations
17.
Greub, Gilbert, Alessandro Cozzi‐Lepri, Bruno Ledergerber, et al.. (2002). Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy. AIDS. 16(14). 1967–1969. 95 indexed citations
18.
Telenti, Amalio. (2002). New developments in laboratory monitoring of HIV-1 infection. Clinical Microbiology and Infection. 8(3). 137–143. 5 indexed citations
19.
Bally, Frank, Raquel Martínez, Solange Peters, Philippe Sudre, & Amalio Telenti. (2000). Polymorphism of HIV Type 1 Gag p7/p1 and p1/p6 Cleavage Sites: Clinical Significance and Implications for Resistance to Protease Inhibitors. AIDS Research and Human Retroviruses. 16(13). 1209–1213. 99 indexed citations
20.
Bassetti, Stefano, Manuel Battegay, Martin Rickenbach, et al.. (1999). Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued ?. IRIS. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bonaventura Clotet Breakdown of academic impact, for papers by Michael M. Lederman Breakdown of academic impact, for papers by H. Clifford Lane Breakdown of academic impact, for papers by Michael S. Saag Breakdown of academic impact, for papers by Michael P. Busch Breakdown of academic impact, for papers by Martin Hirsch Breakdown of academic impact, for papers by Jeffrey N. Martin Breakdown of academic impact, for papers by John Phair Breakdown of academic impact, for papers by Brian Gazzard Breakdown of academic impact, for papers by Margaret A. Fischl
Rankless by CCL
2026